from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1821/secA2

LFCtreatmentdescriptionclass of inhibitor

-1.474

Amikacinug/mL Amikacintranslation

-2.212

Cap5-10ug/mL Capreomycintranslation

-3.072

Rox10-50 ug/mL Roxithromycintranslation

-0.483

SM2-5 ug/mL Streptomycintranslation

-2.856

Tet5-10 ug/mL Tetracyclinetranslation

-0.441

Rif0.2-5ug/mL Rifampicintranscription

-0.410

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.480

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.815

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.898

CPZ10-50 ug/mL Chlorpromazinerespiration

1.379

Clofazimine10-13 ug/mL Clofaziminerespiration

0.551

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.444

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.123

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.058

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.859

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.976

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

2.264

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.180

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.732

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.413

KCN5-20 ug/mL Potassium cyaniderespiration

-0.347

NaN30.2-2 mM Sodium aziderespiration

0.035

Nigericin50 uM Nigericinrespiration

-0.539

TRC10-150 ug/mL Triclosanrespiration

0.703

TRZ10-25 ug/mL Thioridazinerespiration

-2.557

Valinomycin0.5-10 uM Valinomycinrespiration

0.125

ZnSO42 mM ZnSO4respiration

0.298

menadione6-10 ug/mL Menadionerespiration

0.815

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.301

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.304

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.269

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.296

NRP_1Non-replicating persistence stage 1dosRassociated

0.395

Amp0.2mg/mL AmpicillincellWall

0.331

Cephalexin20-100 ug/mL CephalexincellWall

-0.427

Cerulenin0.32-5 ug/mL CerulenincellWall

0.242

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.362

EMB10-20 ug/mL EthambutolcellWall

0.613

Eta12-40 ug/mL EthionamidecellWall

0.940

INH0.2-0.4 ug/mL IsoniazidcellWall

0.436

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.151

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.131

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.539

BZA0.12 mg/mL BenzamidearomaticAmides

-0.388

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.243

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.713

H2O24 mM hydrogen peroxideDNAdamaging

-0.582

Levo10 ug/mL LevofloxacinDNAdamaging

-0.424

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.421

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.371

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.241

UVUV-irradiationDNAdamaging

-0.134

ARP41-4 ug/mL Antitubercular compound ARP4?

0.000

Antimycin12.5-50 ug/mL Antimycin A?

0.086

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.314

PA_110-50 ug/mL Antitubercular compound PA-1?

0.229

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.010

PA8240.2-2 ug/mL PA-824?

-0.318

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.063

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.810

Verapamil50 uM Verapamil?

0.267

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.145

methoxatin10-20 ug/mL Methoxatin?